4-[(20-Azido-3,6,9,12,15,18-hexaoxaicosyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione

Catalog No. :
ACXZDV431
CAS No. :
2624181-62-8
Molecular Formula :
C27H38N6O10
Molecular Weight :
606.63

IUPAC Name:4-((20-azido-3,6,9,12,15,18-hexaoxaicosyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione

4-[(20-Azido-3,6,9,12,15,18-hexaoxaicosyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$757.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(20-Azido-3,6,9,12,15,18-hexaoxaicosyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
IUPAC Name4-((20-azido-3,6,9,12,15,18-hexaoxaicosyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
Molecular FormulaC27H38N6O10
Molecular Weight606.63
SMILESO=C1N(C(C2=C1C=CC=C2NCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-])=O)C(C(N3)=O)CCC3=O
InChI KeyGZXCJGDZCUFESD-UHFFFAOYSA-N
SynonymPoma-PEG6-N3;4-[2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 4-[(20-azido-3,6,9,12,15,18-hexaoxaeicos-1-yl)amino]-2-(2,6-dioxo-3-piperidinyl)-
CAS No.2624181-62-8

Synthetic Route by SureRoute

1. ACXZDV431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZDV431 route product structure diagram
    ACXZDV4312624181-62-8
Inquiry

2. ACXZDV431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXZDV431 route product structure diagram
    ACXZDV4312624181-62-8
Inquiry

Comments (0)